NDC Code | 83703-037-03 |
Package Description | 10 SYRINGE, GLASS in 1 CARTON (83703-037-03) / .5 mL in 1 SYRINGE, GLASS (83703-037-04) |
Product NDC | 83703-037 |
Product Type Name | VACCINE |
Proprietary Name | Flucelvax Quadrivalent |
Non-Proprietary Name | Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/darwin/11/2021 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/inftt-16-0610/2016 Antigen (mdck Cell Derived, Propiolactone Inactivated) |
Dosage Form | INJECTION, SUSPENSION |
Usage | INTRAMUSCULAR |
Start Marketing Date | 20230701 |
End Marketing Date | 20240731 |
Marketing Category Name | BLA |
Application Number | BLA125408 |
Manufacturer | Bamboo US BidCo LLC |
Substance Name | INFLUENZA A VIRUS A/DARWIN/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
Strength | 15; 15; 15; 15 |
Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |